A CT-based Radiomics Nomogram for Differentiation of Renal Angiomyolipoma Without Visible Fat from Homogeneous Clear Cell Renal Cell Carcinoma
Overview
Authors
Affiliations
Objectives: To develop and validate a radiomics nomogram for preoperative differentiating renal angiomyolipoma without visible fat (AML.wovf) from homogeneous clear cell renal cell carcinoma (hm-ccRCC).
Methods: Ninety-nine patients with AML.wovf (n = 36) and hm-ccRCC (n = 63) were divided into a training set (n = 80) and a validation set (n = 19). Radiomics features were extracted from corticomedullary phase and nephrographic phase CT images. A radiomics signature was constructed and a radiomics score (Rad-score) was calculated. Demographics and CT findings were assessed to build a clinical factors model. Combined with the Rad-score and independent clinical factors, a radiomics nomogram was constructed. Nomogram performance was assessed with respect to calibration, discrimination, and clinical usefulness.
Results: Fourteen features were used to build the radiomics signature. The radiomics signature showed good discrimination in the training set (AUC [area under the curve], 0.879; 95%; confidence interval [CI], 0.793-0.966) and the validation set (AUC, 0.846; 95% CI, 0.643-1.000). The radiomics nomogram showed good calibration and discrimination in the training set (AUC, 0.896; 95% CI, 0.810-0.983) and the validation set (AUC, 0.949; 95% CI, 0.856-1.000) and showed better discrimination capability (p < 0.05) compared with the clinical factor model (AUC, 0.788; 95% CI, 0.683-0.893) in the training set. Decision curve analysis demonstrated the nomogram outperformed the clinical factors model and radiomics signature in terms of clinical usefulness.
Conclusions: The CT-based radiomics nomogram, a noninvasive preoperative prediction tool that incorporates the Rad-score and clinical factors, shows favorable predictive efficacy for differentiating AML.wovf from hm-ccRCC, which might assist clinicians in tailoring precise therapy.
Key Points: • Differential diagnosis between AML.wovf and hm-ccRCC is rather difficult by conventional imaging modalities. • A radiomics nomogram integrated with the radiomics signature, demographics, and CT findings facilitates differentiation of AML.wovf from hm-ccRCC with improved diagnostic efficacy. • The CT-based radiomics nomogram might spare unnecessary surgery for AML.wovf.
Zhan W, Luo Y, Luo H, Zhou Z, Yin N, Li Y Front Cardiovasc Med. 2024; 11:1462451.
PMID: 39544308 PMC: 11560751. DOI: 10.3389/fcvm.2024.1462451.
A CT-based radiomics nomogram for predicting histologic grade and outcome in chondrosarcoma.
Li X, Shi X, Wang Y, Pang J, Zhao X, Xu Y Cancer Imaging. 2024; 24(1):50.
PMID: 38605380 PMC: 11007871. DOI: 10.1186/s40644-024-00695-7.
Chen W, Lin G, Chen Y, Cheng F, Li X, Ding J BMC Cancer. 2024; 24(1):418.
PMID: 38580939 PMC: 10996101. DOI: 10.1186/s12885-024-12026-x.
Zechuan L, Tianshi L, Tiantian L, Shoujin C, Hang Y, Ziping Y Front Oncol. 2024; 14:1334706.
PMID: 38505597 PMC: 10949893. DOI: 10.3389/fonc.2024.1334706.
Yu X, Zou Y, Wang L, Yang H, Jiao J, Yu H Front Oncol. 2024; 13:1269589.
PMID: 38288103 PMC: 10822955. DOI: 10.3389/fonc.2023.1269589.